News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Daily News Datos de Registro Revelan el Ascenso y Caída de la Bivalirudina frente a la Heparina en la Realización de PCI Primarias Yael L. Maxwell November 11, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2016 Shelley Wood September 30, 2016
News Daily News TCTMD’s Top 10 Most Popular Stories for September 2016 Shelley Wood September 30, 2016
News Daily News Según un Extenso Análisis Europeo el Uso Actual de FAINE se asocia a un Mayor Riesgo de Insuficiencia Cardíaca Michael O'Riordan September 30, 2016
News Daily News Current NSAID Use Linked to Increased Risk of Heart Failure, Large European Analysis Shows Michael O'Riordan September 30, 2016
News Daily News Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies Michael O'Riordan September 27, 2016
News Daily News CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study Michael O'Riordan September 22, 2016
News Daily News Guerra de los Medios Británicos: BMJ, Lancet Siguen Recortando el Uso de Estatinas Todd Neale September 19, 2016
News Daily News Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice Michael O'Riordan September 16, 2016
News Daily News Demasiados Elementos en Juego: La Existencia de Diferentes y Discordantes Directrices Hace que la Valoración del Riesgo de ECV sea Confusa Michael O'Riordan September 16, 2016
News Conference News ESC 2016 Optimal Approach for BP Lowering Debated Amid New J-Curve Signals in Stable CAD Todd Neale September 09, 2016
News Daily News Short-term DAPT Not Necessarily the Best Option for All, Especially After Complex PCI Yael L. Maxwell September 02, 2016
News Daily News El Tratamianto Antiplaquetario Doble a Corto Plazo No es la Mejor Opción para Todos, Especialmente Tras una PCI Compleja Yael L. Maxwell September 02, 2016
News Conference News ESC 2016 When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis Michael O'Riordan August 31, 2016